AIZN vs MET

For growth investors, MetLife, Inc.

(MET) is the stronger pick with 10. 2% revenue growth year-over-year, versus 7. 9% for Assurant, Inc. 5. 25% Subordinat (AIZN). Assurant, Inc. 5. 25% Subordinat (AIZN) offers the better valuation at 1. 1x trailing P/E (1. 0x forward), making it the more compelling value choice. Analysts rate MetLife, Inc. (MET) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Assurant, Inc.

5. 25% Subordinat (AIZN) is the cheapest at 1. 1x versus MetLife, Inc. at 16. 4x. On forward P/E, Assurant, Inc. 5. 25% Subordinat is actually cheaper at 1. 0x.

Over the past 5 years, MetLife, Inc.

(MET) delivered a total return of +32. 9%, compared to -1. 0% for Assurant, Inc. 5. 25% Subordinat (AIZN). Over 10 years, the gap is even starker: MET returned +153. 9% versus AIZN's -0. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Assurant, Inc.

5. 25% Subordinat (AIZN) is the lower-risk stock at 0. 81β versus MetLife, Inc. 's 1. 09β — meaning MET is approximately 34% more volatile than AIZN relative to the S&P 500. On balance sheet safety, Assurant, Inc. 5. 25% Subordinat (AIZN) carries a lower debt/equity ratio of 38% versus 70% for MetLife, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), MetLife, Inc.

(MET) is pulling ahead at 10. 2% versus 7. 9% for Assurant, Inc. 5. 25% Subordinat (AIZN). On earnings-per-share growth, the picture is similar: Assurant, Inc. 5. 25% Subordinat grew EPS 20. 3% year-over-year, compared to -19. 2% for MetLife, Inc.. Over a 3-year CAGR, AIZN leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Assurant, Inc.

5. 25% Subordinat (AIZN) is the more profitable company, earning 6. 8% net margin versus 4. 4% for MetLife, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AIZN leads at 8. 5% versus 6. 0% for MET. At the gross margin level — before operating expenses — AIZN leads at 77. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Assurant, Inc.

5. 25% Subordinat (AIZN) trades at 1. 0x forward P/E versus 8. 0x for MetLife, Inc. — 7. 1x cheaper on a one-year earnings basis.

All stocks in this comparison pay dividends.

Assurant, Inc. 5. 25% Subordinat (AIZN) offers the highest yield at 17. 1%, versus 2. 9% for MetLife, Inc. (MET).

For long-horizon retirement investors, Assurant, Inc.

5. 25% Subordinat (AIZN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 81), 17. 1% yield). Both have compounded well over 10 years (AIZN: -0. 7%, MET: +153. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.